{"id":"https://openalex.org/W2132277825","doi":"https://doi.org/10.2337/diaclin.30.1.3","title":"Choosing GLP-1 Receptor Agonists or DPP-4 Inhibitors: Weighing the Clinical Trial Evidence","display_name":"Choosing GLP-1 Receptor Agonists or DPP-4 Inhibitors: Weighing the Clinical Trial Evidence","alternate_titles":[],"publication_year":2012,"publication_date":"2012-01-01","ids":{"openalex":"https://openalex.org/W2132277825","doi":"https://doi.org/10.2337/diaclin.30.1.3","mag":"2132277825"},"language":"en","primary_location":{"id":"doi:10.2337/diaclin.30.1.3","doi":"https://doi.org/10.2337/diaclin.30.1.3","is_oa":false,"landing_page_url":"https://doi.org/10.2337/diaclin.30.1.3","pdf_url":null,"source":{"id":"https://openalex.org/S31960566","display_name":"Clinical Diabetes","issn_l":"0891-8929","issn":["0891-8929","1945-4953"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","ki-jl-1","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Diabetes","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2132277825"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5000792801","display_name":"Timothy Reid","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1314179348","display_name":"Mercy Health System","ror":"https://ror.org/008xr7e22","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1314179348"]},{"id":"https://openalex.org/I3018075036","display_name":"Sanofi (France)","ror":"https://ror.org/02n6c9837","country_code":"FR","type":"company","lineage":["https://openalex.org/I3018075036"]},{"id":"https://openalex.org/I4210113060","display_name":"Sisters of Mercy Health System","ror":"https://ror.org/024zq6d87","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210113060"]}],"countries":["FR","US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Timothy Reid","raw_affiliation_strings":["Note of disclosure:\u2008Dr. Reid has served as a speaker/consultant and received fees/honoraria from Amylin-Lilly, Novo Nordisk, and sanofi-aventis","Timothy Reid, MD, is a practicing physician at Mercy Diabetes Center in Janesville, Wis"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Note of disclosure:\u2008Dr. Reid has served as a speaker/consultant and received fees/honoraria from Amylin-Lilly, Novo Nordisk, and sanofi-aventis","institution_ids":["https://openalex.org/I3018075036"]},{"raw_affiliation_string":"Timothy Reid, MD, is a practicing physician at Mercy Diabetes Center in Janesville, Wis","institution_ids":["https://openalex.org/I1314179348","https://openalex.org/I4210113060"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5000792801"],"corresponding_institution_ids":["https://openalex.org/I1314179348","https://openalex.org/I3018075036","https://openalex.org/I4210113060"],"apc_list":null,"apc_paid":null,"fwci":3.3934,"has_fulltext":false,"cited_by_count":40,"citation_normalized_percentile":{"value":0.92151368,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"30","issue":"1","first_page":"3","last_page":"12"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.9980000257492065},{"id":"https://openalex.org/keywords/dpp-4-inhibitors","display_name":"DPP-4 inhibitors","score":0.9919999837875366},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.8560000061988831},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.9779999852180481},{"id":"https://openalex.org/keywords/weight-effects","display_name":"weight effects","score":0.9010000228881836},{"id":"https://openalex.org/keywords/blood-pressure","display_name":"blood pressure","score":0.8109999895095825},{"id":"https://openalex.org/keywords/lipid-profile","display_name":"lipid profile","score":0.9959999918937683},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.6650000214576721},{"id":"https://openalex.org/keywords/nausea-and-diarrhea","display_name":"nausea and diarrhea","score":0.6309999823570251},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.5379999876022339}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8926407098770142},{"id":"https://openalex.org/C2780966972","wikidata":"https://www.wikidata.org/wiki/Q86","display_name":"Headaches","level":2,"score":0.735369086265564},{"id":"https://openalex.org/C156490143","wikidata":"https://www.wikidata.org/wiki/Q412214","display_name":"Dipeptidyl peptidase-4","level":4,"score":0.7247854471206665},{"id":"https://openalex.org/C2780580376","wikidata":"https://www.wikidata.org/wiki/Q186889","display_name":"Nausea","level":2,"score":0.6231226921081543},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.5630189776420593},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.49718597531318665},{"id":"https://openalex.org/C2776398474","wikidata":"https://www.wikidata.org/wiki/Q424611","display_name":"Glucagon-like peptide-1","level":4,"score":0.4662220776081085},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4620228707790375},{"id":"https://openalex.org/C2781308992","wikidata":"https://www.wikidata.org/wiki/Q2526479","display_name":"Liraglutide","level":4,"score":0.4498519003391266},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.42444857954978943},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.39231979846954346},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.28422218561172485},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.27052730321884155},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.19981297850608826},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.11006048321723938}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.2337/diaclin.30.1.3","doi":"https://doi.org/10.2337/diaclin.30.1.3","is_oa":false,"landing_page_url":"https://doi.org/10.2337/diaclin.30.1.3","pdf_url":null,"source":{"id":"https://openalex.org/S31960566","display_name":"Clinical Diabetes","issn_l":"0891-8929","issn":["0891-8929","1945-4953"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","ki-jl-1","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Diabetes","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320322436","display_name":"Novo Nordisk","ror":"https://ror.org/0435rc536"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":33,"referenced_works":["https://openalex.org/W1559082056","https://openalex.org/W1585447752","https://openalex.org/W1971471384","https://openalex.org/W1981183973","https://openalex.org/W1984740259","https://openalex.org/W1985739127","https://openalex.org/W2004409542","https://openalex.org/W2045063167","https://openalex.org/W2048728983","https://openalex.org/W2050826565","https://openalex.org/W2057913111","https://openalex.org/W2058922633","https://openalex.org/W2071835038","https://openalex.org/W2074142099","https://openalex.org/W2093738306","https://openalex.org/W2098459806","https://openalex.org/W2103058881","https://openalex.org/W2108646121","https://openalex.org/W2113367996","https://openalex.org/W2114927834","https://openalex.org/W2118762421","https://openalex.org/W2129377335","https://openalex.org/W2129578585","https://openalex.org/W2133244310","https://openalex.org/W2137352234","https://openalex.org/W2140952918","https://openalex.org/W2146901298","https://openalex.org/W2159198773","https://openalex.org/W2160001758","https://openalex.org/W2170606300","https://openalex.org/W2171512247","https://openalex.org/W2509949587","https://openalex.org/W2798494090"],"related_works":["https://openalex.org/W2052771129","https://openalex.org/W3014755863","https://openalex.org/W2030228579","https://openalex.org/W2016726554","https://openalex.org/W2091480327","https://openalex.org/W2411164089","https://openalex.org/W2470254746","https://openalex.org/W2008591744","https://openalex.org/W3195071552","https://openalex.org/W188668629"],"abstract_inverted_index":{"IN":[0],"BRIEF":[1],"Comparative":[2],"trials":[3],"show":[4],"that":[5],"there":[6],"are":[7,46,63],"important":[8],"differences":[9],"between":[10],"and":[11,19,31,37,44,61],"among":[12],"the":[13,38,51,66],"glucagon-like":[14],"peptide-1":[15],"(GLP-1)":[16],"receptor":[17,54],"agonists":[18],"dipeptidyl":[20],"peptidase-4":[21],"(DPP-4)":[22],"inhibitors":[23],"with":[24,48,65],"respect":[25],"to":[26],"glycemic":[27],"lowering,":[28],"weight":[29],"effects,":[30],"effects":[32],"on":[33],"systolic":[34],"blood":[35],"pressure":[36],"lipid":[39],"profile.":[40],"Nausea,":[41],"diarrhea,":[42],"headaches,":[43],"dizziness":[45],"common":[47,64],"both":[49],"of":[50],"available":[52],"GLP-1":[53],"agonists.":[55],"Upper":[56],"respiratory":[57],"tract":[58],"infections,":[59],"nasopharyngitis,":[60],"headaches":[62],"DPP-4":[67],"inhibitors.":[68],"Ongoing":[69],"safety":[70],"evaluations":[71],"should":[72],"provide":[73],"a":[74],"clear":[75],"picture":[76],"regarding":[77],"long-term":[78],"safety.":[79]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2132277825","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":7},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":12},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
